174 related articles for article (PubMed ID: 21503586)
21. The effects of anesthesia on cerebral tissue oxygen tension: use of EPR oximetry to make repeated measurements.
Swartz HM; Taie S; Miyake M; Grinberg OY; Hou H; el-Kadi H; Dunn JF
Adv Exp Med Biol; 2003; 530():569-75. PubMed ID: 14562753
[TBL] [Abstract][Full Text] [Related]
22. Effect on regrowth delay in a murine tumor of scheduling split-dose irradiation based on direct pO2 measurements by electron paramagnetic resonance oximetry.
O'Hara JA; Goda F; Demidenko E; Swartz HM
Radiat Res; 1998 Nov; 150(5):549-56. PubMed ID: 9806597
[TBL] [Abstract][Full Text] [Related]
23. Potential for EPR oximetry to guide treatment planning for tumors.
O'Hara JA; Goda F; Dunn JF; Swartz HM
Adv Exp Med Biol; 1997; 411():233-42. PubMed ID: 9269432
[No Abstract] [Full Text] [Related]
24. Dynamic changes in oxygenation of intracranial tumor and contralateral brain during tumor growth and carbogen breathing: a multisite EPR oximetry with implantable resonators.
Hou H; Dong R; Li H; Williams B; Lariviere JP; Hekmatyar SK; Kauppinen RA; Khan N; Swartz H
J Magn Reson; 2012 Jan; 214(1):22-8. PubMed ID: 22033225
[TBL] [Abstract][Full Text] [Related]
25. Response to radioimmunotherapy correlates with tumor pO2 measured by EPR oximetry in human tumor xenografts.
O'Hara JA; Blumenthal RD; Grinberg OY; Demidenko E; Grinberg S; Wilmot CM; Taylor AM; Goldenberg DM; Swartz HM
Radiat Res; 2001 Mar; 155(3):466-73. PubMed ID: 11182798
[TBL] [Abstract][Full Text] [Related]
26. Metronomic treatment in immunocompetent preclinical GL261 glioblastoma: effects of cyclophosphamide and temozolomide.
Ferrer-Font L; Arias-Ramos N; Lope-Piedrafita S; Julià-Sapé M; Pumarola M; Arús C; Candiota AP
NMR Biomed; 2017 Sep; 30(9):. PubMed ID: 28570014
[TBL] [Abstract][Full Text] [Related]
27. Characterization of a clinically used charcoal suspension for in vivo EPR oximetry.
Desmet CM; Tran LBA; Danhier P; Gallez B
MAGMA; 2019 Apr; 32(2):205-212. PubMed ID: 30209636
[TBL] [Abstract][Full Text] [Related]
28. In vivo observation of intracellular oximetry in perfluorocarbon-labeled glioma cells and chemotherapeutic response in the CNS using fluorine-19 MRI.
Kadayakkara DK; Janjic JM; Pusateri LK; Young WB; Ahrens ET
Magn Reson Med; 2010 Nov; 64(5):1252-9. PubMed ID: 20860007
[TBL] [Abstract][Full Text] [Related]
29. Changes in oxygenation of intracranial tumors with carbogen: a BOLD MRI and EPR oximetry study.
Dunn JF; O'Hara JA; Zaim-Wadghiri Y; Lei H; Meyerand ME; Grinberg OY; Hou H; Hoopes PJ; Demidenko E; Swartz HM
J Magn Reson Imaging; 2002 Nov; 16(5):511-21. PubMed ID: 12412027
[TBL] [Abstract][Full Text] [Related]
30. [Effect of perfluorochemicals on tissue PO2 levels in a subcutaneous 9L rat glioma model].
Kokunai T; Korosue K; Kuwamura K; Tamaki N; Matsumoto S
Gan To Kagaku Ryoho; 1984 Oct; 11(10):2207-11. PubMed ID: 6486835
[TBL] [Abstract][Full Text] [Related]
31. Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors.
Folkins C; Man S; Xu P; Shaked Y; Hicklin DJ; Kerbel RS
Cancer Res; 2007 Apr; 67(8):3560-4. PubMed ID: 17440065
[TBL] [Abstract][Full Text] [Related]
32. Collaboration between hepatic and intratumoral prodrug activation in a P450 prodrug-activation gene therapy model for cancer treatment.
Ma J; Waxman DJ
Mol Cancer Ther; 2007 Nov; 6(11):2879-90. PubMed ID: 17989319
[TBL] [Abstract][Full Text] [Related]
33. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
Laterra J; Nam M; Rosen E; Rao JS; Lamszus K; Goldberg ID; Johnston P
Lab Invest; 1997 Apr; 76(4):565-77. PubMed ID: 9111517
[TBL] [Abstract][Full Text] [Related]
34. Metronomic treatment of malignant glioma xenografts with irinotecan (CPT-11) inhibits angiogenesis and tumor growth.
Takano S; Kamiyama H; Mashiko R; Osuka S; Ishikawa E; Matsumura A
J Neurooncol; 2010 Sep; 99(2):177-85. PubMed ID: 20066473
[TBL] [Abstract][Full Text] [Related]
35. Synergistic combination of hyperoxygenation and radiotherapy by repeated assessments of tumor pO2 with EPR oximetry.
Hou H; Dong R; Lariviere JP; Mupparaju SP; Swartz HM; Khan N
J Radiat Res; 2011; 52(5):568-74. PubMed ID: 21799293
[TBL] [Abstract][Full Text] [Related]
36. Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.
Kesari S; Schiff D; Doherty L; Gigas DC; Batchelor TT; Muzikansky A; O'Neill A; Drappatz J; Chen-Plotkin AS; Ramakrishna N; Weiss SE; Levy B; Bradshaw J; Kracher J; Laforme A; Black PM; Folkman J; Kieran M; Wen PY
Neuro Oncol; 2007 Jul; 9(3):354-63. PubMed ID: 17452651
[TBL] [Abstract][Full Text] [Related]
37. Modulation of the antitumor activity of metronomic cyclophosphamide by the angiogenesis inhibitor axitinib.
Ma J; Waxman DJ
Mol Cancer Ther; 2008 Jan; 7(1):79-89. PubMed ID: 18202011
[TBL] [Abstract][Full Text] [Related]
38. Effect of a topical vasodilator on tumor hypoxia and tumor oxygen guided radiotherapy using EPR oximetry.
Hou H; Abramovic Z; Lariviere JP; Sentjurc M; Swartz H; Khan N
Radiat Res; 2010 May; 173(5):651-8. PubMed ID: 20426665
[TBL] [Abstract][Full Text] [Related]
39. Direct and Repeated Measurement of Heart and Brain Oxygenation Using In Vivo EPR Oximetry.
Khan N; Hou H; Swartz HM; Kuppusamy P
Methods Enzymol; 2015; 564():529-52. PubMed ID: 26477264
[TBL] [Abstract][Full Text] [Related]
40. Tumor pO2 assessments in human xenograft tumors measured by EPR oximetry: location of paramagnetic materials.
O'Hara JA; Blumenthal RD; Grinberg OY; Grinberg S; Wilmot C; Goldenberg DM; Swartz HM
Adv Exp Med Biol; 2003; 530():205-14. PubMed ID: 14562718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
